Evaluation of liposomal formulations of amniotic membrane in treatment skin aging after laser rejuvenation

Evaluation of safety and effectiveness of liposomal formulations of amniotic membrane in treatment skin aging after laser rejuvenation (phase I / II clinical trial)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N25

Enrollment

Registered

2023-02-18

Start date

2023-02-20

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin aging. Atrophic disorder of skin, unspecified

Interventions

Intervention 1: Control group: 10 patients use Amnion's non-liposomal product (Zist Sakht Bonyan Pars company) topically immediately after fractional CO2 laser rejuvenation in three sessions with an i

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 20-60 Having middle wrinkles in face region

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding History of cancer Patients with a new history of gel and Botox injections People with Mental Disorders Active infection in the face

Design outcomes

Primary

Measure	Time frame
The amount of wrinkles. Timepoint: Before treatment and six month after the last session. Method of measurement: Visio face.	—

Secondary

Measure	Time frame
Inflammation. Timepoint: After each session of treatment. Method of measurement: Questionnaire and visit.;Intensity of pain. Timepoint: Treatment time. Method of measurement: Questionnaire and visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsona zare

Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026